WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR April 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: APRIL ISSUE PUBLISHED

    APRIL 2024 Issue has been successfully launched on APRIL 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

THE DIAGNOSTIC ROLE OF BRAFV600E MUTATION AND ULTRASOUND FEATURES IN INDETERMINATE THYROID CYTOLOGY

Alaa Al-Maaitah*, Moaath Alsmady, Mira Younis, Ahmad Al-Alwan, Dana Alsmady, Shatha Dmour, Handan Ankaralı, Malek Zihlif, Mohammad Al-Shehab, Heyam Awad, Nader Albsoul, Orhan Alimoglu

ABSTRACT

Background: Fine needle aspiration biopsies of thyroid nodules are indeterminate in approximately 30% of the cases, so several preoperative molecular markers have been studied to improve the diagnostic utility of such nodules. We aimed to study the role of BRAF V600E mutation and ultrasonography to predict malignancy preoperatively for indeterminate thyroid nodules. Methods: This is a retrospective study that included 78 indeterminate nodules. DNA was extracted from formalin-fixed paraffin-embedded tissues and BRAFV600E mutation was analyzed by direct sequencing. Neck ultrasound records were evaluated for the major sonographic features including size, margin, halo, echogenicity, calcifications, vascularity and cervical lymphadenopathy. A “p” value less than 0.05 was considered statistically significant. Results: Seventy-eight indeterminate nodules were distributed in Bethesda categories III, IV and V as 38, 17, 23, respectively. Malignant cases in each category were 6/38, 5/17, 12/23, respectively. All of them were diagnosed with papillary thyroid cancer. Four cases out of 78 harbored BRAFV600E mutation (1 in category III, 3 in category V). Accordingly, malignancy was significantly predicted by cytology (p=0.009) and BRAFV600E mutation (p=0.001). The latter exhibited 100% specificity. However, the overall sensitivity of BRAFV600E mutation was 17.4% and increased only to 25% in category V. Sonographic features that corresponded significantly to malignancy were microcalcifications and cervical lymphadenopathy (p=0.026 and p=0.017, respectively). But only ill-defined margin was associated with BRAFV600E mutation (p= 0.032). Ultrasound features had low sensitivity (15.4%-84.6%), but higher specificity (9.7%-93.9%) of which microcalcifications and ill-defined margin were the most specific signs. Conclusions: BRAFV600E mutation was a significant predictor of malignancy for indeterminate thyroid nodules. However, it was most useful in Bethesda category V. Microcalcifications, ill-defined margin and cervical lymphadenopathy were the most suspicious sonographic features of malignancy.

[Full Text Article] [Download Certificate]